Dr. Jahan is an expert in thoracic oncology known for his compassion. He is dedicated to finding a cure for pleural mesothelioma and has contributed extensive research to the cause.

About Dr. Jahan

Dr. Thierry M. Jahan is the clinical professor of the department of medicine at the University of California San Francisco. He is a widely recognized leader in thoracic oncology and an expert in malignant pleural mesothelioma treatment.

  • Medical Degree and Residencies

    MD, George Washington University School of Medicine, 1987.
    Dr. Jahan completed his residency at the Department of Medicine Cedars-Sinai Medical Center/UCLA from 1987 to 1990.

  • Professorship

    Clinical Professor of Medicine, Division of Hematology/Oncology UCSF Helen Diller Family Comprehensive Cancer Center, Mount Zion campus Department of Medicine University of California, San Francisco

Dr. Jahan further expanded his knowledge with a fellowship in hematology/oncology at the University of California San Francisco after completing an internal medicine internship, residency and fellowship at Cedars Sinai Medical Center. From there, Dr. Jahan settled in to a rewarding career at UCSF, which was named the 7th best cancer center in the country by U.S. News and World Report.

Dr. Jahan’s Accomplishments

  • Board certified for medical oncology
  • Principal investigator on numerous thoracic oncology clinical trials
  • Recipient of the Medical House Staff Outstanding Teacher Award

Get Connected To Dr. Thierry Jahan

Photograph of Dr Jahan
Dr. Jahan is the clinical professor of the department of medicine at the University of California San Francisco. He is an accomplished mesothelioma specialist who has been working toward treatment of the disease for the past 20 years.

Why Choose Dr. Thierry Jahan?
  • He advocates multimodal therapy, currently the most effective treatment for mesothelioma patients
  • His extensive research in pleural mesothelioma makes him an expert in this narrow field
  • He is a widely regarded thoracic oncologist




Dr. Jahan’s Mesothelioma Research

Dr. Jahan has worked in the field of mesothelioma for approximately 20 years. During this time he has helped transform treatment goals from merely palliative to decidedly curative. His deep knowledge of thoracic oncology combined with a dedication to treating pleural mesothelioma makes him an insightful and caring doctor.

“There’s been an explosion of possibilities in this field like never before and it’s extremely gratifying to know our patients have a shot at doing much better than they’ve ever had before.” —Dr. Jahan

When it comes to treatment, Dr. Jahan encourages patients to explore a multimodal approach. Multimodal treatments include a combination of several types of treatment, such as chemotherapy, radiation and surgery. Occasionally, emerging treatments may also be interspersed with more traditional therapies. Multimodal treatment has been shown to lead to the best possible life expectancy for those fighting mesothelioma.

Although Dr. Jahan’s true passion lies in beating mesothelioma altogether, he recognizes the importance of improving the quality of life for current patients. For patients ineligible for aggressive surgeries, palliative care can lower side effects and reduce painful symptoms. Dr. Jahan’s work in this type of care garnered a Friend of the Palliative Care Service Award in 2006.

Clinical Trials under Dr. Jahan

As the principal investigator for many clinical trials focused on thoracic oncology, Dr. Jahan has left a considerable mark on the world of pleural mesothelioma research. Although his experience is varied, Dr. Jahan has a specific interest in testing target therapies in mesothelioma as either single agents or in combination with chemotherapy and/or radiation.

One of the clinical trials Dr. Jahan is currently leading focuses on the safety and efficacy of a weakened strain of Listeria. It is being used in conjunction with standard chemotherapy as a treatment for pleural mesothelioma.

The Listeria bacteria used in this study has been genetically modified to mitigate any harmful effects associated with it, while maintaining its ability to stimulate potent immune responses. Dr. Jahan currently acts as principal investigator on several clinical trials.

Dr. Jahan is known for his outstanding compassion and empathy in patient interactions. He is lauded by many for going above and beyond the role of doctor by genuinely caring about the future of his patients. If you would like more information on this knowledgeable and compassionate doctor, get connected to Dr. Jahan with our free Doctor Match program now.

Dr. Jahan’s Compassionate Approach